Funding · Company
SYNDEVRX INC
Cambridge, MABiotech & Pharma
SYNDEVRX INC of Cambridge, MA has disclosed $53M across 2 Form D offerings filed with the SEC between Dec 20, 2023 and Oct 10, 2024.
$53M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$23M
Form D · Dec 20, 2023 ↗
Q4 2023
· 2 amendments, first filed Dec 30, 2021
· target $30M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001455364Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →